Expression and roles of FGFR1-4 in GBM are heterogeneous, with FGFR1 being the most extensively studied, with a key role in GSC maintenance, proliferation and GBM therapeutic resistance [33–36]. The gene discussed is FGFR1; the disease is glioblastoma.